Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study
- PMID: 26491371
- PMCID: PMC4598214
- DOI: 10.2147/CCIDE.S93066
Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study
Abstract
Dental caries is the most common chronic disease of childhood. Cariogram is a well-recognized algorithm-based software program based on different caries-related risk factors and intended to aid clinicians in performing more objective and consistent dental caries risk assessments. This type of approach precedes the diagnosis of caries and allows the dentist to identify at-risk patients and then take appropriate preventive measures before caries develop further. One of the etiological factors favoring the development of dental caries is the mutans streptococci. These acidogenic dental plaque inhabitants can be effectively antagonized by the activity of bacteriocins released by the probiotic Streptococcus salivarius M18 (salivarius M18). Moreover, salivarius M18 after colonizing the human oral mucosa produces the enzymes dextranase and urease that are able to counteract plaque formation and saliva acidity, respectively. Seventy-six subjects at high risk of dental caries were randomized and then either treated or not treated for 90 days with an oral formulation containing the oral probiotic salivarius M18 (Carioblis(®)). The results indicate that the use of salivarius M18 increases the chances of avoiding new dental caries development in children, and its application could be proposed as a new tool in the dentist's armory to be adopted in subjects considered at high risk on the basis of their Cariogram outcome.
Keywords: BLIS M18; Streptococcus mutans; Streptococcus sobrinus; bacteriocins; caries prediction; dextranase; plaque; salivary pH; urease.
Figures
Similar articles
-
Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial.J Med Microbiol. 2013 Jun;62(Pt 6):875-884. doi: 10.1099/jmm.0.056663-0. Epub 2013 Feb 28. J Med Microbiol. 2013. PMID: 23449874 Clinical Trial.
-
Randomized Clinical Trial of Oral Probiotic Streptococcus salivarius M18 on Salivary Streptococcus mutans in Preprimary Children.Int J Clin Pediatr Dent. 2023 Mar-Apr;16(2):259-263. doi: 10.5005/jp-journals-10005-2527. Int J Clin Pediatr Dent. 2023. PMID: 37519958 Free PMC article.
-
Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial.Cureus. 2022 Mar 18;14(3):e23282. doi: 10.7759/cureus.23282. eCollection 2022 Mar. Cureus. 2022. PMID: 35449617 Free PMC article.
-
The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci.N Z Dent J. 1991 Jul;87(389):80-3. N Z Dent J. 1991. PMID: 1956623 Review.
-
Mutans streptococci caries and chlorhexidine.J Can Dent Assoc. 1996 Sep;62(9):700, 703-7. J Can Dent Assoc. 1996. PMID: 8908872 Review.
Cited by
-
Evaluation of the effects of Streptococcus salivarius M18 and K12 probiotic bacteria on the Streptococcus mutans in saliva: A randomized clinical trial.Dent Res J (Isfahan). 2024 Jul 12;21:39. eCollection 2024. Dent Res J (Isfahan). 2024. PMID: 39188385 Free PMC article.
-
Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics.Front Microbiol. 2023 Mar 28;14:1161155. doi: 10.3389/fmicb.2023.1161155. eCollection 2023. Front Microbiol. 2023. PMID: 37056747 Free PMC article. Review.
-
In Vivo Colonization with Candidate Oral Probiotics Attenuates Colonization and Virulence of Streptococcus mutans.Appl Environ Microbiol. 2021 Mar 1;87(4):e02490-20. doi: 10.1128/AEM.02490-20. Epub 2020 Dec 4. Appl Environ Microbiol. 2021. PMID: 33277269 Free PMC article.
-
Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.Oral Health Prev Dent. 2023 Aug 29;21:259-270. doi: 10.3290/j.ohpd.b4328987. Oral Health Prev Dent. 2023. PMID: 37724895 Free PMC article.
-
Comparative evaluation of different probiotic products on salivary Streptococcus mutans and Lactobacillus level in caries risk population.J Conserv Dent. 2020 Nov-Dec;23(6):619-623. doi: 10.4103/JCD.JCD_467_20. Epub 2021 Feb 11. J Conserv Dent. 2020. PMID: 34083920 Free PMC article.
References
-
- Bagramian RA, Garcia-Godoy F, Volpe AR. The global increase in dental caries. A pending public health crisis. Am J Dent. 2009;22:3–8. - PubMed
-
- Vachirarojpisan T, Shinada K, Kawaguchi Y, Laungwechakan P, Somkote T, Detsomboonrat P. Early childhood caries in children aged 6–19 months. Community Dent Oral Epidemiol. 2004;32(2):133–142. - PubMed
-
- Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007;369:51–59. - PubMed
-
- ten Cate JM, Zaura E. The numerous microbial species in oral biofilms: how could antibacterial therapy be effective? Adv Dent Res. 2012;24(2):108–111. - PubMed
LinkOut - more resources
Full Text Sources
Medical